http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2856596-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2675a41a0b9549145c2135ff642bb3ff
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412
filingDate 2003-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_898ae98f4b7a73141aef303cff08efd4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a50c3f816132670d6e2b86f889ae62d
publicationDate 2004-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2856596-A1
titleOfInvention NOVEL PSYCHIATRIC DRUG ASSOCIATION AND THE USE OF AN INVERSE HISTAMINE H3 RECEPTOR ANTAGONIST OR AGONIST TO PREPARE A MEDICAMENT PREVENTING ADVERSE EFFECTS OF PSYCHOTROPES.
abstract A medicament comprising, in a pharmaceutically acceptable vehicle, an anti-psychotic or an antidepressant (A), exhibiting only an adverse effect of body weight gain or sedation and an antagonist and / or inverse agonist (B) of the H3 receptor of the histamine, said histamine H3 receptor antagonist and / or inverse agonist being present in a therapeutically effective amount to achieve at least one of the following three effects: suppressing or at least limiting the undesirable effect of weight gain, suppression or limitation of the undesirable effect on the vigilance, increase of the pro-cognitive effect of the treatment. Use of such an antagonist or inverse agonist for the preparation of a medicament for providing at least one of said three effects in a patient treated with such an antipsychotic or antidepressant.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8829041-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9186353-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9108948-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8853390-B2
priorityDate 2003-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6248765-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0982300-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003096808-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574898

Total number of triples: 49.